We do not earn a commission from this provider.
RENN Health review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
RENN Health publishes one figure per drug and nothing else: semaglutide as low as $149 a month, tirzepatide at $199. The bundles it advertises are never priced.
- States not published
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
This link pays us nothing. It's here because the price is checkable.
The verdict
A homepage that promises predictable pricing and drug pages that publish a floor. The LegitScript link is the one checkable thing here.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Compounded semaglutide
- As low as $149 a month
- Compounded tirzepatide
- $199 a month
- Three- and six-month bundles
- Advertised on the homepage, priced nowhere
- Dose ladder
- None published
- Certification
- Its own LegitScript listing is linked from the footer
- States served
- Not published on any page we read
Pros and cons
What we like
- The footer links the company's own LegitScript record rather than only claiming a certification.
- The tirzepatide figure is stated flat at $199 rather than as a floor, so one of the two numbers is a commitment.
- The drug pages explain the mechanism and the supervision model before they reach for the price.
- The terms state the jurisdiction the company operates from, which most sellers in this batch leave out entirely.
What could be better
- The semaglutide figure is "as low as", with nothing published about what raises it.
- The bundle discounts the homepage promises are not priced on any page we read.
- The terms name the brand and a state, with no street address, so the FDA warning-letter screen could not be run and no absence is claimed.
- No state list, no billing cadence and no first-month rate anywhere on the four pages we read.
What it is
A structured virtual weight-loss program built on compounded semaglutide and tirzepatide, with NAD+ and testosterone therapy as separate lanes. The drug pages lead with mechanism and supervision rather than with a plan table.
The footer links the company's own LegitScript listing, which is unusual and useful — most sellers assert a certification without giving you the record to look at, and a seal shows issuance rather than what it covers.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutideStated as "as low as" a month. No plan term, cadence or dose ladder published. | not published | $149 | not comparable | September 2026 |
| Compounded tirzepatidePrinted flat on the page headline. No plan term or cadence published. | not published | $199 | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
The homepage promises "Predictable monthly pricing starting at $149/month" and "3 and 6-month bundles with stack discounts". The semaglutide page then says "START FOR AS LOW AS $149/MO" and the tirzepatide page says "$199/MO", and that is the entire pricing disclosure.
The bundles the homepage advertises are not priced on either drug page. Neither is a dose ladder, a billing cadence or a first-month rate.
"As low as" and "predictable" are doing opposite work in the same sentence. A floor is precisely the number that does not stay put, and an unqualified floor is how a headline in this market stops being a price.
Who it's wrong for
- Skip it if you want the discount you were promised quantified. The three- and six-month bundles are advertised and never priced.
- Skip it if you need to know what a higher dose costs. No ladder is published and nothing says the price holds.
- Skip it if you want the terms named beside the number. Ondra Health writes the billing cadence into the same line as the price.
Medications available
- Compounded semaglutideCompoundedAs low as $149 a month
A floor. Nothing published says what moves it.
- Compounded tirzepatideCompounded$199 a month
Printed flat rather than as a floor.
Is RENN Health legit?
RENN Health is operated by RENN Health, Headquartered in California — no street address published. We read that off the company’s own terms and conditions on September 2026.
Pharmacy, prescribers and safety checks
- Who prescribesNot named beyond "proper clinical supervision" on the drug pages
- Pharmacy namedNot disclosed
- CertificationIts own LegitScript listing is linked, so the record can be checked
- FDA warning-letter screenNot run. A state but no street address is published
- States servedNot published
Common questions
How much does RENN Health cost?
The semaglutide page says as low as $149 a month and the tirzepatide page says $199 a month. Neither figure carries a plan term, a billing cadence or a dose ladder.
What do the three- and six-month bundles cost?
The homepage advertises bundles with stack discounts but does not price them, and neither drug page carries a bundle rate. The discount is promised and never quantified.
Can I check the company's certification?
Yes. The footer links its own LegitScript listing rather than simply claiming one, which lets a reader see the record directly instead of taking the claim at face value.
Why we gave RENN Health a C
Read the full grading rationale
The homepage promises 'Predictable monthly pricing starting at $149/month' and '3 and 6-month bundles with stack discounts'. The drug pages then publish one figure each and nothing else: 'START FOR AS LOW AS $149/MO' on semaglutide and a bare '$199/MO' on tirzepatide. The bundles the homepage advertises are not priced on either page, so the discount a reader was told about is unquantified, and the semaglutide figure is a floor rather than a rate. Nothing states whether the price holds across doses. RENN Health does link its own LegitScript listing from the footer, which is a checkable disclosure and more than most sellers here offer. The terms name RENN Health, say it is headquartered in California, and give no street address, so the FDA warning-letter screen was NOT RUN and no absence is claimed. No state list on the four pages read.
How we reviewed RENN Health
- We read the homepage, both drug pages and the terms and conditions first-hand at desktop width, looking for any bundle price or dose ladder.
- The absence claim is a census: four pages read, two figures published, neither with a term attached and no bundle priced on any of them.
- No FDA warning-letter screen was run: the terms name a state of headquarters but no street address, and this screen matches on domain and address together.
The 2 pages we read — all on
- Semaglutide page
START YOUR JOURNEY START FOR AS LOW AS $149/MO
- Tirzepatide page
A dual‑action GLP‑1/GIP option designed to support advanced weight‑loss goals through a structured virtual model. START YOUR JOURNEY $199/MO
This link pays us nothing. It's here because the price is checkable.
Alternatives to RENN Health
| Provider | Grade | Cheapest price |
|---|---|---|
| Coivas | CCaveat | $149/mo |
| Corsica Health | CCaveat | $149/mo |
| Fitish | AVerified | $149/mo |
| Harper Meds | CCaveat | $149/mo |
| Heva Health | BMinor gap | $149/mo |